Breast Cancer: Circular RNAs Mediating Efficacy in Preclinical In Vivo Models
Cancer Genomics - Proteomics · 2023
DOI: 10.21873/cgp.20377 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Genomics - Proteomics, 2023. Verfasst von Ulrich H Weidle und 2 weiteren Autor:innen. Beteiligte Einrichtung: Roche Pharma Research and Early Development (pRED), Large Molecule Research, Roche Innovation Center Munich, Penzberg, Germany weidle49@t-online.de. Hauptthemen laut MEDLINE: Breast Neoplasms, MicroRNAs. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Roche Pharma Research and Early Development (pRED), Large Molecule Research, Roche Innovation Center Munich, Penzberg, Germany weidle49@t-online.de.
- Roche Pharma Research and Early Development (pRED), Large Molecule Research, Roche Innovation Center Munich, Penzberg, Germany.
- Roche Pharma Research and Early Development (pRED), Large Molecule Research, Roche Innovation Center Munich, Penzberg, Germany ulrich.brinkmann@roche.com.
Zitieren
APA
Weidle, U. H., Hsia, H. E., & Brinkmann, U. (2023). Breast Cancer: Circular RNAs Mediating Efficacy in Preclinical In Vivo Models. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20377
Vancouver
Weidle UH, Hsia HE, Brinkmann U. Breast Cancer: Circular RNAs Mediating Efficacy in Preclinical In Vivo Models. Cancer Genomics - Proteomics. 2023. doi:10.21873/cgp.20377
BibTeX
@article{Weidle2023,
author = {Weidle, Ulrich H and Hsia, Hung-En and Brinkmann, Ulrich},
title = {Breast Cancer: Circular RNAs Mediating Efficacy in Preclinical In Vivo Models},
journal = {Cancer Genomics - Proteomics},
year = {2023},
doi = {10.21873/cgp.20377}
}
EUVIMED